Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Equity Ratio: 2011-2025

Historic Equity Ratio for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to 0.01.

  • Lifecore Biomedical's Equity Ratio fell 87.47% to 0.01 in Q2 2025 from the same period last year, while for May 2025 it was 0.01, marking a year-over-year decrease of 87.47%. This contributed to the annual value of 0.01 for FY2025, which is 87.47% down from last year.
  • Lifecore Biomedical's Equity Ratio amounted to 0.01 in Q2 2025, which was down 40.48% from 0.01 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Equity Ratio ranged from a high of 0.44 in Q1 2022 and a low of -0.06 during Q3 2023.
  • Over the past 3 years, Lifecore Biomedical's median Equity Ratio value was 0.01 (recorded in 2025), while the average stood at 0.03.
  • Per our database at Business Quant, Lifecore Biomedical's Equity Ratio plummeted by 118.88% in 2023 and then skyrocketed by 946.45% in 2024.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Equity Ratio stood at 0.37 in 2021, then tumbled by 30.12% to 0.26 in 2022, then tumbled by 97.76% to 0.01 in 2023, then skyrocketed by 946.45% to 0.06 in 2024, then tumbled by 87.47% to 0.01 in 2025.
  • Its Equity Ratio stands at 0.01 for Q2 2025, versus 0.01 for Q1 2025 and 0.06 for Q4 2024.